Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice

PLoS One. 2015 Dec 15;10(12):e0145237. doi: 10.1371/journal.pone.0145237. eCollection 2015.

Abstract

We previously identified heme oxygenase 1 (HO-1) as a specific target of miR-155, and inhibition of HO-1 activity restored the capacity of miR-155-/- CD4+ T cells to promote antigen-driven inflammation after adoptive transfer in antigen-expressing recipients. Protoporphyrins are molecules recognized for their modulatory effect on HO-1 expression and function. In the present study, we investigated the effect of protoporphyrin treatment on the development of autoimmunity in miR-155-deficient mice. MiR-155-mediated control of HO-1 expression in promoting T cell-driven chronic autoimmunity was confirmed since HO-1 inhibition restored susceptibility to experimental autoimmune encephalomyelitis (EAE) in miR-155-deficient mice. The increased severity of the disease was accompanied by an enhanced T cell infiltration into the brain. Taken together, these results underline the importance of miR-155-mediated control of HO-1 expression in regulating the function of chronically-stimulated T cells in EAE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / pathology
  • Disease Susceptibility
  • Encephalomyelitis, Autoimmune, Experimental / drug therapy*
  • Encephalomyelitis, Autoimmune, Experimental / genetics*
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Heme Oxygenase-1 / antagonists & inhibitors
  • Heme Oxygenase-1 / metabolism
  • Lymph Nodes / drug effects
  • Lymph Nodes / immunology
  • Mice, Inbred C57BL
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Protoporphyrins / pharmacology
  • Protoporphyrins / therapeutic use*
  • Spleen / drug effects
  • Spleen / immunology
  • Th1 Cells / drug effects
  • Th17 Cells / drug effects

Substances

  • MicroRNAs
  • Mirn155 microRNA, mouse
  • Protoporphyrins
  • protoporphyrin IX
  • Heme Oxygenase-1

Grants and funding

This work was supported by Fonds de la Recherche Scientifique (FRS-FNRS; grant number: 3.4590.11F), an Interuniversity Attraction Poles (IAP) (Contract P7/39), the Alice and David Van Buuren Foundation and The Rose and Jean Hoguet Foundation. JZ was supported by The China Scholarship Council (CSC) and an intramural PhD fellowship of the Institute for Medical Immunology.